JVSCX | VMVAX | JVSCX / VMVAX | |
Total Expense Ratio | 1.80 | 0.07 | 2,571% |
Annual Report Gross Expense Ratio | 2.82 | 0.07 | 4,029% |
Fund Existence | 14 years | 14 years | - |
Gain YTD | 1.688 | 7.952 | 21% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 85.1M | 32.5B | 0% |
Annual Yield % from dividends | 0.00 | 2.17 | - |
Returns for 1 year | -7.72 | 4.87 | -159% |
Returns for 3 years | 35.41 | 42.44 | 83% |
Returns for 5 years | 45.76 | 64.89 | 71% |
Returns for 10 years | 26.22 | 102.58 | 26% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LFAK | 132.05 | N/A | N/A |
Stone Ridge 2052 Longevity Income ETF | |||
OVB | 20.58 | -0.03 | -0.15% |
Overlay Shares Core Bond ETF | |||
FIDI | 24.52 | -0.12 | -0.48% |
Fidelity International High Div ETF | |||
EMXC | 68.93 | -0.53 | -0.76% |
iShares MSCI Emerging Mkts ex China ETF | |||
EQAL | 52.25 | -0.44 | -0.84% |
Invesco Russell 1000 Equal Weight ETF |